Validation of AclarusDx™, a blood-based transcriptomic signature for the diagnosis of Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 32, Issue 1, 2012, Pages 169-181

  Fehlbaum Beurdeley, Pascale ^a   Sol, Olivier ^a   Désiré, Laurent ^a   Touchon, Jacques ^a   Dantoine, Thierry ^b   Vercelletto, Martine ^c   Gabelle, Audrey ^a   Jarrige, Anne Charlotte ^a   Haddad, Raphaël ^a   Lemarié, Jean Christophe ^d   Zhou, Weiyin ^e   Hampel, Harald ^f   Einstein, Richard ^e   Vellas, Bruno ^g  

^a GUI DE CHAULIAC HOSPITAL   (France)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

^d Effi Stat   (France)

^e Exonhit Inc   (United States)

^f GOETHE UNIVERSITY   (Germany)

^g Serv Univ Psychiat l'Enfant l'A   (France)

Author keywords

Alzheimer's disease; biomarker; blood; gene expression; molecular signature; transcriptome

Indexed keywords

AMYLOID; BCL2 RELATED PROTEIN A1; BIOLOGICAL MARKER; CASPASE 4; JANUS KINASE 2; RNA; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD SAMPLING; CELL DEATH; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE LOCUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN METABOLISM; RNA EXTRACTION; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS;

EID: 84867511423     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120637     Document Type: Article

References (59)

1. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
2. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 263-269.
3. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G,Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 6, 734-746.
4. Rezai-Zadeh K, Gate D, Szekely CA, Town T (2009) Can peripheral leukocytes be used as Alzheimer's disease biomarkers? Expert Rev Neurother 9, 1623-1633.
5. Bell RD, Zlokovic BV (2009) Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol 118, 103-113.
6. Webster JA, Gibbs JR, Clarke J, Ray M, Zhang W, Holmans P, Rohrer K, Zhao A, Marlowe L, Kaleem M, McCorquodale DS 3rd, Cuello C, Leung D, Bryden L, Nath P, Zismann VL, Joshipura K, Huentelman MJ, Hu-Lince D, Coon KD, Craig DW, Pearson JV,NACC-Neuropathology Group, Heward CB, Reiman EM, Stephan D, Hardy J, Myers AJ (2009) Genetic control of human brain transcript expression in Alzheimer disease. Am J Hum Genet 84, 445-458.
7. Berget SM, Moore C, Sharp PA (1977) Spliced segments at the 5- terminus of adenovirus 2 late mRNA. Proc Natl Acad Sci U S A 74, 3171-3175.
8. Lander ES (2001) Initial sequencing and analysis of the human genome. Nature 409, 860-921.
9. Modrek B, Lee C (2002) A genomic view of alternative splicing. Nat Genet 30, 13-19.
10. Kampa D, Cheng J, Kapranov P, Yamanaka M, Brubaker S, Cawley S, Drenkow J, Piccolboni A, Bekiranov S, Helt G, Tammana H, Gingeras TR (2004) Novel RNAs identified from an in-depth analysis of the transcriptome of human chromosomes 21 and 22. Genome Res 14, 331-342.
11. Venables JP (2004) Aberrant and alternative splicing in cancer. Cancer Res 64, 7647-7654.
12. Miller JA, Horvath S, Geschwind DH (2010) Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways. Proc Natl Acad Sci U S A 107, 12698-12703.
13. Avramopoulos D, Szymanski M, Wang R, Bassett S (2011) Gene expression reveals overlap between normal aging and Alzheimer's disease genes. Neurobiol Aging 32, 2319.e27-34.
14. ZhouW, Calciano MA, Jordan H, Brenner M, Johnson S,Wu D, Lei L, Pallares D, Beurdeley P, Rouet F, Gill PS, Bracco L, Soucaille C, Einstein R (2009) High resolution analysis of the human transcriptome: Detection of extensive alternative splicing independent of transcriptional activity. BMC Genet 10, 63.
15. Andŕe F, Michiels S, Dessen P, Scott V, Suciu V, Uzan C, LazarV, Lacroix L,Vassal G, Spielmann M,Vielh P, Delaloge S (2009) Exonic expression profiling of breast cancer and benign lesions: A retrospective analysis. Lancet Oncol 10, 381-390.
16. Fehlbaum-Beurdeley P, Jarrige-Le Prado AC, Pallares D, Carriere J, Guihal C, Soucaille C, Rouet F, Drouin D, Sol O, Jordan H, Wu D, Lei L, Einstein R, Schweighoffer F, Bracco L (2010) Toward an Alzheimer's disease diagnosis via high-resolution blood gene expression. Alzheimers Dement 6, 25-38.
17. Folstein MR, Folstein SE, McHugh PR (1975) "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
18. Geman D, d'Avignon C, Naiman DQ, Winslow RL (2004) Classifying gene expression profiles from pairwise mRNA comparisons. Stat Appl Genet Mol Biol 3, Article 19.
19. Coste J, Jourdain P, Pouchot J (2006) A gray zone assigned to inconclusive results of quantitative diagnostic tests: Application to the use of brain natriuretic peptide for diagnosis of heart failure in acute dyspneic patients. Clin Chem 52, 2229-2235.
20. Crosio C, Casciati A, Iaccarino C, Rotilio G, Carri MT (2006) Bcl2a1 serves as a switch in death of motor neurons in amyotrophic lateral sclerosis. Cell Death Differ 13, 2150-2153.
21. Li Y, Xu Z, Ford GD, Croslan DR, Cairobe T, Li Z, Ford BD (2007) Neuroprotection by neuregulin-1 in a rat model of permanent focal cerebral ischemia. Brain Res 1184, 277-283.
22. Salminen A, Suuronen T, Kaarniranta K (2008) ROCK, PAK, and Toll of synapses in Alzheimer's disease. Biochem Biophys Res Commun 371, 587-590.
23. Lukiw WJ, Cui JG, Marcheselli VL, Bodker M, Botkjaer A, Gotlinger K, Serhan CN, Bazan NG (2005) A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest 115, 2774-2783.
24. Zambrano A, Otth C, Mujica L, Concha II, Maccioni RB (2007) Interleukin-3 prevents neuronal death induced by amyloid peptide. BMC Neurosci 8, 82.
25. Shaw S, Bencherif M, Marrero MB (2002) Janus kinase 2, an early target of alpha 7 nicotinic acetylcholine receptormediated neuroprotection against Abeta-(1-42) amyloid. J Biol Chem 277, 44920-44924.
26. Chiba T, Yamada M, Sasabe J, Terashita K, Shimoda M, Matsuoka M, Aiso S (2009) Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons. Mol Psychiatry 14, 206-222.
27. Chaudhury AR, Gerecke KM,Wyss JM,Morgan DG, Gordon MN, Carroll SL (2003) Neuregulin-1 and erbB4 immunoreactivity is associated with neuritic plaques in Alzheimer disease brain and in a transgenic model of Alzheimer disease. J Neuropathol Exp Neurol 62, 42-54.
28. Blom ES, Wang Y, Skoglund L, Hansson AC, Ubaldi M, Lourdusamy A, Sommer WH, Mielke M, Hyman BT, Heilig M, Lannfelt L, Nilsson LN, Ingelsson M (2010) Increased mRNAlevels of TCF7L2 andMYCof the Wnt pathway in Tg-ArcSwe mice and Alzheimer's disease brain. Int J Alzheimers Dis 2011, 936580.
29. Qian W, Yin X, Hu W, Shi J, Gu J, Grundke-Iqbal I, Iqbal K, Gong CX, Liu F (2011) Activation of protein phosphatase 2B and hyperphosphorylation of Tau in Alzheimer's disease. J Alzheimers Dis 4, 617-627.
30. Rezai-Zadeh K, Gate D, Szekely CA, Town T (2009) Can peripheral leukocytes be used as Alzheimer's disease biomarkers? Expert Rev Neurother 9, 1623-1633.
31. Borroni B, Agosti C, Marcello E, Di Luca M, Padovani A (2010) Blood cell markers in Alzheimer Disease: Amyloid Precursor Protein form ratio in platelets. Exp Gerontol 45, 53-56.
32. Huang J, Shi W, Zhang J, Chou JW, Paules RS, Gerrish K, Li J, Luo J, Wolfinger RD, Bao W, Chu TM, Nikolsky Y, Nikolskaya T, Dosymbekov D, Tsyganova MO, Shi L, Fan X, Corton JC, Chen M, Cheng Y, TongW, Fang H, Bushel PR (2010) Genomic indicators in the blood predict drug-induced liver injury. Pharmacogenomics J 10, 267-277.
33. Aarøe J, Lindahl T, Dumeaux V, Saebø S, Tobin D, Hagen N, Skaane P, Lonneborg A, Sharma P, Børresen-Dale AL (2010) Gene expression profiling of peripheral blood cells for early detection of breast cancer. Breast Cancer Res 12, R7.
34. Cao K, Chen-Plotkin AS, Plotkin JB, Wang LS (2010) Agecorrelated gene expression in normal and neurodegenerative human brain tissues. Plos One 5, e13098.
35. TwineNA, Janitz K,WilkinsMR,JanitzM(2011) Whole transcriptome sequencing reveals gene expression and splicing differences in brain regions affected by Alzheimer's disease. Plos One 6, e16266.
36. Blalock EM, Chen KC, Sharrow K, Herman JP, Porter NM, Foster TC, Landfield PW (2003) Gene microarrays in hippocampal aging: Statistical profiling identifies novel processes correlated with cognitive impairment. J Neurosci 23, 3807-3819.
37. Abdel Rassoul R, Alves S, Pantesco V, De Vos J, Michel B, Perret M, Mestre-Franćes N, Verdier JM, Devau G (2010) Distinct transcriptome expression of the temporal cortex of the primate Microcebus murinus during brain aging versus Alzheimer's disease-like pathology. Plos One 5, e12770.
38. Sullivan PF, Fan C, Perou CM (2006) Evaluating the comparability of gene expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet 141B, 261-268.
39. Cai C, Langfelder P, Fuller TF, Oldham MC, Luo R, van den Berg LH, Ophoff RA, Horvath S (2010) Is human blood a good surrogate for brain tissue in transcriptional studies? BMC Genomics 11, 589.
40. Takahashi M, Hayashi H,WatanabeY, Sawamura K, Fukui N, Watanabe J, Kitajima T, Yamanouchi Y, Iwata N, Mizukami K, Hori T, Shimoda K, Ujike H, Ozaki N, Iijima K, Takemura K, Aoshima H, Someya T (2010) Diagnostic classification of schizophrenia by neural network analysis of blood-based gene expression signatures. Schizophr Res 119, 210-218.
41. Scherzer CR, Eklund AC, Morse LJ, Liao Z, Locascio JJ, Fefer D, Schwarzschild MA, Schlossmacher MG, Hauser MA, Vance JM, Sudarsky LR, Standaert DG, Growdon JH, Jensen RV, Gullans SR (2007) Molecular markers of early Parkinson's disease based on gene expression in blood. Proc Natl Acad Sci U S A 104, 955-960.
42. Stamova B, Xu H, Jickling G, Bushnell C, Tian Y, Ander BP, Zhan X, Liu D, Turner R, Adamczyk P, Khoury JC, Pancioli A, Jauch E, Broderick JP, Sharp FR (2010) Gene expression profiling of blood for the prediction of ischemic stroke. Stroke 41, 2171-2177.
43. Maes OC, Xu S, Yu B, Chertkow HM,Wang E, Schipper HM (2007) Transcriptional profiling of Alzheimer blood mononuclear cells by microarray. Neurobiol Aging 28, 1795-1809.
44. Grunblatt E, Bartl J, Zehetmayer S, Ringel TM, Bauer P, Riederer P, Jacob CP (2009) Gene expression as peripheral biomarkers for sporadic Alzheimer's disease. J Alzheimers Dis 16, 627-634.
45. Rye PD, Booij BB, Grave G, Lindahl T, Kristiansen L, Andersen HM, Horndalsveen PO, Nygaard HA, Naik M, Hoprekstad D, Wetterberg P, Nilsson C, Aarsland D, Sharma P, L̈onneborg A (2011) A novel blood test for the early detection of Alzheimer's disease. J Alzheimers Dis 23, 121-129.
46. Booij BB, Lindahl T,Wetterberg P, SkaaneNV, Sæbø S, Feten G, Rye PD, Kristiansen LI, Hagen N, Jensen M, B°ardsen K, Winblad B, Sharma P, L̈onneborgA(2011)Agene expression pattern in blood for the early detection of Alzheimer's disease. J Alzheimers Dis 23, 109-119.
47. Shi L, Campbell G, Jones WD, Campagne F, Wen Z, Walker SJ, Su Z, Chu TM, Goodsaid FM, Pusztai L, Shaughnessy JD Jr, Oberthuer A, Thomas RS, Paules RS, Fielden M, Barlogie B, ChenW, Du P, Fischer M, Furlanello C, Gallas BD, Ge X, Megherbi DB, Symmans WF, Wang MD, Zhang J, Bitter H, Brors B, Bushel PR, Bylesjo M, Chen M, Cheng J, Cheng J, Chou J, Davison TS, Delorenzi M, Deng Y, Devanarayan V, Dix DJ, Dopazo J, Dorff KC, Elloumi F, Fan J, Fan S, Fan X, Fang H, Gonzaludo N, Hess KR, Hong H, Huan J, Irizarry RA, Judson R, Juraeva D, Lababidi S, Lambert CG, Li L, Li Y, Li Z, Lin SM, Liu G, Lobenhofer EK, Luo J, LuoW, McCallMN, Nikolsky Y, Pennello GA, Perkins RG, Philip R, Popovici V, Price ND, Qian F, Scherer A, Shi T, Shi W, Sung J, Thierry-Mieg D, Thierry-Mieg J, Thodima V, Trygg J, Vishnuvajjala L,Wang SJ,Wu J,Wu Y, Xie Q, YousefWA, Zhang L, Zhang X, Zhong S, Zhou Y, Zhu S, Arasappan D, BaoW, Lucas AB, Berthold F, Brennan RJ, Buness A, Catalano JG, Chang C, Chen R, Cheng Y, Cui J, Czika W. (2010) The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol 28, 827-838.
48. Tan ZS, Beiser AS, Vasan RS, Roubenoff R, Dinarello CA, Harris TB, Benjamin EJ, Au R, Kiel DP, Wolf PA, Seshadri S (2007) Inflammatory markers and the risk of Alzheimer disease: The Framingham Study. Neurology 68, 1902-1908.
49. Luchsinger JA, Gustafson DR (2009) Adiposity, type 2 diabetes, and Alzheimer's disease. J Alzheimers Dis 16, 693-704.
50. RidkerPM(2004) High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: From concept to clinical practice to clinical benefit. Am Heart J 148, S19-S26.
51. Haffner S, Temprosa M, Crandall J, Fowler S, Goldberg R, Horton E, Marcovina S, Mather K, Orchard T, Ratner R, Barrett-Connor E (2005) Diabetes Prevention Program Research Group. Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance. Diabetes 54, 1566-1572.
52. He W, Lu Y, Qahwash I, Hu X-Y, Chang A, Yan R (2004) Reticulon family members modulate BACE1 activity and amyloid-beta peptide generation. Nature Med 10, 959-965.
53. Qian W, Yin X, Hu W, Shi J, Gu J, Grundke-Iqbal I, Iqbal K, Gong CX, Liu F (2011) Activation of protein phosphatase 2B and hyperphosphorylation of tau in Alzheimer's disease. J Alzheimers Dis 23, 617-627.
54. Braak E, Griffing K, Arai K, Bohl J, Bratzke H, Braak H (1999) Neuropathology of Alzheimer's disease: What is new since A. Alzheimer? Eur Arch Psychiatry Clin Neurosci 249(Suppl 3), 14-22.
55. Caccamo A, Maldonado MA, Bokov AF, Majumder S, Oddo S (2010) CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 107, 22687-22692.
56. Saura CA, Valero J (2011) The role of CREB signaling in Alzheimer's disease and other cognitive disorders. Rev Neurosci 22, 153-169.
57. Lee Y, Lee J, Kwon I, Nakajima Y, Ohmiya Y, Son GH, Lee KH, Kim K (2010) Coactivation of the CLOCK-BMAL1 complex by CBP mediates resetting of the circadian clock. J Cell Sci 123, 3547-3557.
58. Witting W, Kwa IH, Eikelenboom P, Mirmiran M, Swaab DF (1990) Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease. Biol Psychiatry 27, 563-572.
59. Boivin DB, James FO,Wu A, Cho-Park PF, Xiong H, Sun ZS (2003) Circadian clock genes oscillate in human peripheral blood mononuclear cells. Blood 102, 4143-4145.